NIKKEI 225
39,029.44 -40.24 (-0.10%) HANG SENG
19,272.53 -363.69 (-1.85%) CRUDE OIL
79.22 -0.58 (-0.73%) GOLD FUTURES
2,419.80 -18.70 (-0.77%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
55,819.64 +3,003.22 (+5.69%)
FUJIFILM Holdings Corp (FJI.SG)
| Previous close | 20.17 |
| Open | 20.38 |
| Bid | 20.35 x 100000 |
| Ask | 20.62 x 100000 |
| Day's range | 20.38 - 20.38 |
| 52-week range | 16.82 - 21.34 |
| Volume | |
| Avg. volume | 36 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksFUJIFILM's (FUJIY) Q4 Earnings and Revenues Increase Y/Y
FUJIFILM's (FUJIY) fiscal fourth-quarter performance is driven by healthy revenue growth in the Business Innovation, Materials and Consumer Imaging segment.
Globe NewswireFujifilm Healthcare Europe launches lifelike ESD training simulator EndoGel
RATINGEN, Germany, April 19, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM) procedures. This innovative simulator, available in two versions - EndoGel for ESD and EndoGel for ESD/POEM - represents a significant advance in endoscopic training. This simulator aims to improve the skills of endoscopy professionals across Europe
- Business Live
More than 120 jobs at risk as major North East employer launches restructure
A total of 126 jobs are potentially set to go at the three North-east Fujifilm Diosynth Biotechnologies UK sites
